Case File
efta-efta00628137DOJ Data Set 9OtherFrom: "Kirschner, Elyse" <1
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00628137
Pages
2
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: "Kirschner, Elyse" <1
To: Jeffrey Epstein <jeevacation®gmail.com>
Subject: RE:
Date: Fri, 26 Apr 2013 17:56:22 +0000
Attachments: Assignment_and_Assumption_Agreement.pdEpdf
I don't recall that being the reason.
I found the attached document (page A-3). It shows that AIF IV Management, Inc. transferred an interest in Apollo
Management IV, LP to BFP when BFP was formed. I've asked Ada to see a copy of the LP agreement for Apollo
Management IV. We'd like to see who the other partners of Apollo Management IV were.
Elyse G. Kirschner I Partner
McDermott Will & Emery LLP J 340 Madison Avenue, New York, NY 10173
I www.mwe.com
From: Jeffrey Epstein [mailto:[email protected]]
Sent: Friday, April 26, 2013 1:28 PM
To: Kirschner, Elyse
Subject:
is it possible that the only reason that ap iv ltd was added as an Ip. was to make sure that all entities were not
disregarded for tax purposes, and that a partnership requires at least two entites,? ? even though it is a sub s ,
for Ip purposes i believe it qualfires as a non disregarded entity, any memories?
***********************************************************
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jeevacation®gmail.com, and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
grip*
grip*
****
• r****
****
**a*
IRS Circular 230 Disclosure: To comply with requirements imposed by the IRS, we inform you that any U.S. federal tax advice
contained herein (including any attachments), unless specifically stated otherwise, is not intended or written to be used, and
cannot be used, for the purposes of (i) avoiding penalties under the Internal Revenue Code or (ii) promoting, marketing or
recommending to another party any transaction or matter herein.
This message is a PRIVILEGED AND CONFIDENTIAL communication. This message and all attachments are a private
communication sent by a law firm and may be confidential or protected by privilege. If you are not the intended recipient, you
are hereby notified that any disclosure, copying, distribution or use of the information contained in or attached to this message
is strictly prohibited. Please notify the sender of the delivery error by replying to this message, and then delete it from your
EFTA00628137
system. Thank you.
Please visit http://www.mwe.com/ for more information about our Firm.
EFTA00628138
Technical Artifacts (3)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.